Impaired autophagosomes and lysosomes in neuronopathic Gaucher disease
- PMID: 20458183
- DOI: 10.4161/auto.6.5.12047
Impaired autophagosomes and lysosomes in neuronopathic Gaucher disease
Abstract
Gaucher disease is an inherited autosomal recessive disease caused by mutations of acid β-glucosidase, a lysosomal hydrolase specific for degradation of glucosylceramide and glucosylsphingosine in the glycosphingolipid metabolic pathway. Clinically, Gaucher disease is classified into three types: type 1 is a visceral disease, whereas types 2 and 3 are acute and chronic neuronopathic variants, respectively. In types 2 and 3, the CNS pathology displays neuronal inclusions and neuron death. The underlying mechanism(s) by which the glycosphingolipid storage leads to this pathology is not fully understood. A mouse model whose phenotype mimicked that of the human neuronopathic variants was generated in our lab. In the brain of this model, abnormal autophagosomes and lysosomes implicate autophagy in the neuronal degeneration of Gaucher disease.
Similar articles
-
Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration.Hum Mol Genet. 2014 Feb 15;23(4):843-54. doi: 10.1093/hmg/ddt468. Epub 2013 Sep 24. Hum Mol Genet. 2014. PMID: 24064337 Free PMC article.
-
Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.Hum Mol Genet. 2010 Mar 15;19(6):1088-97. doi: 10.1093/hmg/ddp580. Epub 2010 Jan 4. Hum Mol Genet. 2010. PMID: 20047948 Free PMC article.
-
Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3.Neurobiol Dis. 2003 Dec;14(3):595-601. doi: 10.1016/j.nbd.2003.08.016. Neurobiol Dis. 2003. PMID: 14678774
-
Neuronal forms of Gaucher disease.Handb Exp Pharmacol. 2013;(216):405-19. doi: 10.1007/978-3-7091-1511-4_20. Handb Exp Pharmacol. 2013. PMID: 23563668 Review.
-
Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165875. doi: 10.1016/j.bbadis.2020.165875. Epub 2020 Jun 6. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 32522631 Review.
Cited by
-
A Comparative Biochemical and Pathological Evaluation of Brain Samples from Knock-In Murine Models of Gaucher Disease.Int J Mol Sci. 2024 Feb 2;25(3):1827. doi: 10.3390/ijms25031827. Int J Mol Sci. 2024. PMID: 38339105 Free PMC article.
-
Deregulation of mTORC1-TFEB axis in human iPSC model of GBA1-associated Parkinson's disease.Front Neurosci. 2023 Jun 2;17:1152503. doi: 10.3389/fnins.2023.1152503. eCollection 2023. Front Neurosci. 2023. PMID: 37332877 Free PMC article.
-
Autophagic flux is impaired in the brain tissue of Tay-Sachs disease mouse model.PLoS One. 2023 Mar 16;18(3):e0280650. doi: 10.1371/journal.pone.0280650. eCollection 2023. PLoS One. 2023. PMID: 36928510 Free PMC article.
-
Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.Front Mol Neurosci. 2022 Aug 3;15:934820. doi: 10.3389/fnmol.2022.934820. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35992201 Free PMC article. Review.
-
Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease.Cells. 2021 Sep 2;10(9):2286. doi: 10.3390/cells10092286. Cells. 2021. PMID: 34571934 Free PMC article.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
